Z-0970-2018 Class III Terminated

Recalled by Randox Laboratories — Kearneysville, WV

FDA device recall Z-0970-2018 was initiated by Randox Laboratories on Aug 11, 2017 and is designated Class III. Reason for recall: The ACTH in Immunoassay Premium and Premium Plus quality control does not meet the quoted reconstituted stability claim in the product IFU. The recall status is terminated (terminated Mar 29, 2019). Affected quantity: 199 Kits.

Recall details

Product Type
Devices
Report Date
Mar 21, 2018
Initiation Date
Aug 11, 2017
Termination Date
Mar 29, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
199 Kits

Product description

Immunoassay Premium Plus Controls (3x4x5mL and 12x5mL packages)

Reason for recall

The ACTH in Immunoassay Premium and Premium Plus quality control does not meet the quoted reconstituted stability claim in the product IFU.

Distribution pattern

Distribution US nationwide.

Code information

Catalog numbers: IA3109 (Lots: 1476EC, 1573EC, 1619EC) IA3110 (Lots 1477EDC, 1599EDC, 1621EC, 1662EC) IA3111 (Lots: 1478EC, 1508EC, 1578EC, 1647EC) IA3112 (Lots: 359199, 377412, 373302, 382147, 382679, 395668, 416979)

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0970-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0970-2018. Report a data issue: hello@regdatalab.com.